Research and Markets: BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/tpt5k6/bbb_technologies) has announced the addition of the "BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030" report to their offering.

This report contains a comprehensive review of the emerging market of BBB technologies and associated drugs used to treat neurological diseases. The report is focused primarily on non-invasive technologies, with other technologies considered as competing in nature.

Topics Covered Include:

  • Research pipeline
  • Technological profiles
  • Recent developments
  • Sales forecasts
  • Competitive market analysis
  • BBB permeable drug development
  • Future opportunities

In addition to the well-known technologies, we have also provided case studies on four other technologies; these are either in direct competition or have been previously worked upon. Our opinion and insights, presented in this study, were influenced by the discussions that we conducted with different technology providers in this industry.

One of the key objectives of this report is to understand the future state of the BBB technologies market. This is done by analyzing the following:

  • Pipeline candidates based on these technologies
  • Size of target consumer segments
  • Expected launch year and countries where these clinical stage candidates are likely to receive commercialization rights
  • Likely price points

The base year for the report is 2014. The report provides market forecasts for the period 2019 - 2030. The figures mentioned in this report are in USD, unless otherwise specified.

Companies Mentioned Include

  • Agate Medical Investments
  • ALS association
  • Angiochem
  • Antea
  • Aphios
  • ArmaGen
  • ArQule
  • Array BioPharma
  • Arrowhead Research Corp
  • Artenga
  • ASCIL Biopharma
  • Asebio
  • Atlas Venture
  • AZ Therapies
  • Bach Pharma
  • Bayer

Key Topics Covered:

1. Preface

2. Executive Summary

3. Blood Brain Barrier: An Introduction

4. Market Overview

5. Neurological Indications: Market Potential

6. BBB Technologies: Underlying Concepts

7. BBB Technology Profiles

8. Case Studies

9. BBB Technologies: Market Forecasting

10. Interview Transcripts

11. Conclusion

12. Appendix 1: Tabulated Data

13. Appendix 2: List Of Companies

For more information visit http://www.researchandmarkets.com/research/tpt5k6/bbb_technologies

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery